Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Camostat Mesylate in COVID-19 Ambulatory Patients
NCT04353284Phase 2Completed
- Sponsor
- Yale University
- Start
- Jun 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of camostat mesilate in coronavirus disease 2019 (COVID-19), sponsored by Yale University. Started Jun 2020; status: completed.
02
Drugs
camostat mesilate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04353284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04353284.